Compare LNG & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LNG | COR |
|---|---|---|
| Founded | 1983 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Other Pharmaceuticals |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.5B | 59.9B |
| IPO Year | 1996 | 2001 |
| Metric | LNG | COR |
|---|---|---|
| Price | $280.58 | $327.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 14 |
| Target Price | $294.87 | ★ $390.62 |
| AVG Volume (30 Days) | ★ 1.5M | 1.4M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.82% | 0.77% |
| EPS Growth | ★ 69.93 | 5.71 |
| EPS | N/A | ★ 15.21 |
| Revenue | $19,976,000,000.00 | ★ $321,332,819,000.00 |
| Revenue This Year | $16.48 | $8.89 |
| Revenue Next Year | $5.89 | $6.75 |
| P/E Ratio | ★ N/A | $21.29 |
| Revenue Growth | ★ 27.21 | 9.31 |
| 52 Week Low | $186.20 | $244.82 |
| 52 Week High | $300.94 | $377.54 |
| Indicator | LNG | COR |
|---|---|---|
| Relative Strength Index (RSI) | 62.51 | 59.44 |
| Support Level | $250.03 | $301.29 |
| Resistance Level | $300.22 | $329.28 |
| Average True Range (ATR) | 6.09 | 8.20 |
| MACD | 1.13 | -0.28 |
| Stochastic Oscillator | 91.93 | 70.07 |
Cheniere Energy is a liquefied natural gas producer with two facilities in Corpus Christi, Texas, and Sabine Pass, Louisiana. It generates most of its revenue through long-term contracts with customers on a fixed- and variable-fee payout structure. It also generates revenue by selling uncontracted LNG to customers on a short or one-time basis. A subsidiary, Cheniere Energy Partners, owns the Sabine Pass facility and trades as a master limited partnership.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.